a Kayyali Chair for Pharmaceutical Industry, College of Pharmacy , King Saud University , Riyadh , Saudi Arabia.
b Department of Biochemistry, College of Pharmacy , Al-Azhar University , Nasr City, Cairo , Egypt.
Artif Cells Nanomed Biotechnol. 2018 Jun;46(4):669-679. doi: 10.1080/21691401.2017.1354301. Epub 2017 Jul 13.
This review traces the journey of nanosomes from administration until elimination, and discusses various biological barriers. The nanosomes are imported into the body through different routes and are localized into specified organ, cell, subcellular locations or organelle compartment. The nanosomes delivery to a specific destination depends on the surface chemistry, size, shape and the presence of specific ligands. Endocytosis/exocytosis cycles are involved in the import and export of the nanosomes. The mononuclear phagocytic system and ATP-binding cassette are universal checkpoints for nanosomes trafficking. The gastrointestinal milieu is the checkpoints for orally administered nanosomes. The mucociliary escalator is a specialized obstacle for inhaled nanosomes. Dermally applied nanosomes are tackled by Langerhans cells and keratinocytes. The nanosomes intended for subcellular destinations are mainly intercepted by lysosomes. Thus, nanosomes intended for biological administration must be designed to escape various barriers. The nanosomes affect cells function by alteration of redox status, and calcium signalling, ultimately, they are exocytosed from the cells.
本综述追溯了纳米体从给药到消除的过程,并讨论了各种生物屏障。纳米体通过不同途径进入体内,并定位于特定的器官、细胞、亚细胞位置或细胞器隔室。纳米体的靶向特定部位取决于表面化学性质、大小、形状和特定配体的存在。内吞/外排循环参与了纳米体的输入和输出。单核吞噬细胞系统和 ATP 结合盒是纳米体转运的通用检查点。胃肠道环境是口服纳米体的检查点。黏膜纤毛的上升是吸入纳米体的特殊障碍。皮肤应用的纳米体由朗格汉斯细胞和角质形成细胞处理。亚细胞定位的纳米体主要被溶酶体拦截。因此,用于生物给药的纳米体必须设计成能够逃避各种屏障。纳米体通过改变氧化还原状态和钙信号来影响细胞功能,最终从细胞中排出。